Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Webster

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Journal of Opioid Management|January 9, 2018
From the Editor: Doctor driven problem or doctor driven solution?Lynn Webster
Pain Medicine (Malden, Mass.)|August 21, 2009
Update on abuse-resistant and abuse-deterrent approaches to opioid formulationsLynn Webster
Pain Medicine (Malden, Mass.)|March 17, 2012
Efficacy and safety of dual-opioid therapy in acute painLynn Webster
Journal of Managed Care & Specialty Pharmacy|September 25, 2015
The Economic Impact of Opioid Use in the Management of Chronic Nonmalignant PainArthur Lipman, Lynn Webster
Journal of Pain Research|June 10, 2024
Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to AccessLynn Webster, Jeffrey Gudin
Journal of Opioid Management|September 14, 2021
Atypical opioids and their effect on respiratory driveLynn Webster, Richard L Rauck
Clinical Therapeutics|April 1, 2015
Novel Buccal Film Formulation of Buprenorphine-Naloxone for the Maintenance Treatment of Opioid Dependence: A 12-Week Conversion StudyJames G Sullivan, Lynn Webster
Journal of Opioid Management|August 28, 2014
Opioid analgesics: does potency matter?Steven D Passik, Lynn Webster
Pain Medicine (Malden, Mass.)|June 6, 2019
Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New ApproachLynn Webster, William K Schmidt
Pain|April 26, 2011
Letter to the editor in response to "The evidence for pharmacological treatment of neuropathic pain," by Finnerup et alJohn F Peppin, Lynn Webster
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Journal of Opioid Management|January 9, 2018
From the Editor: Doctor driven problem or doctor driven solution?Lynn Webster
Pain Medicine (Malden, Mass.)|August 21, 2009
Update on abuse-resistant and abuse-deterrent approaches to opioid formulationsLynn Webster
Pain Medicine (Malden, Mass.)|March 17, 2012
Efficacy and safety of dual-opioid therapy in acute painLynn Webster
Journal of Managed Care & Specialty Pharmacy|September 25, 2015
The Economic Impact of Opioid Use in the Management of Chronic Nonmalignant PainArthur Lipman, Lynn Webster
Journal of Pain Research|June 10, 2024
Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to AccessLynn Webster, Jeffrey Gudin
Journal of Opioid Management|September 14, 2021
Atypical opioids and their effect on respiratory driveLynn Webster, Richard L Rauck
Clinical Therapeutics|April 1, 2015
Novel Buccal Film Formulation of Buprenorphine-Naloxone for the Maintenance Treatment of Opioid Dependence: A 12-Week Conversion StudyJames G Sullivan, Lynn Webster
Journal of Opioid Management|August 28, 2014
Opioid analgesics: does potency matter?Steven D Passik, Lynn Webster
Pain Medicine (Malden, Mass.)|June 6, 2019
Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New ApproachLynn Webster, William K Schmidt
Pain|April 26, 2011
Letter to the editor in response to "The evidence for pharmacological treatment of neuropathic pain," by Finnerup et alJohn F Peppin, Lynn Webster
Pageof 8